| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efb35e154fff5d3177ae8520d41046d5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2531-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2565-543 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b5ce7a6866c4761f940e3ad91208e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c86da3136622d0114302b36c219613a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ec57c1b2848be2e6011900d83710ef7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b06ac1817a5fba071bb13aa8f3fc529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_121119e21cb9cf0919870cbeb162c35d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d56403486bc0475281d69aaec0b7414 |
| publicationDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017342491-A1 |
| titleOfInvention |
Methods and compositions for nucleic acid amplification |
| abstract |
Compositions that are used in nucleic acid amplification in vitro are disclosed, which include a target specific universal (TSU) promoter primer or promoter provider oligonucleotide that includes a target specific (TS) sequence that hybridizes specifically to a target sequence that is amplified and a universal (U) sequence that is introduced into the sequence that is amplified, by using a primer for the universal sequence. Methods of nucleic acid amplification in vitro are disclosed that use one or more TSU oligonucleotides to attached a U sequence to a target nucleic acid in a target capture step and then use a primer for a U sequence in subsequent amplification steps performed in substantially isothermal conditions to make amplification products that contain a U sequence that indicates the presence of the target nucleic acid in a sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020005491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11238613-B2 |
| priorityDate |
2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |